Dexamphetamine Sustained Release Pharmacokinetics and Clinical Validation of Dried Blood Spots

Summary

The pharmacokinetics of 10 to 12 individuals receiving 60 mg of sustained release dexamphetamine will be studied. These individuals have received this medication before in a previous trial where the pharmacodynamics were investigated. This trial will last 5 consecutive days during which blood samples will be drawn for pharmacokinetics analyses. Dried blood spots will also be collected for the clinical validation of the bioanalytical method wherein these are used.

Timeline

Start

2016-11-01

Primary completion

2017-06-01

Completion

2017-06-01

Drugs

Indications